Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Pharmalittle: We're reading about TrumpRx prices, a J&J psoriasis pill, and much more

Summary by STAT
Johnson & Johnson won approval for a daily psoriasis pill that rivals benefits of injectables and could roil a multibillion-dollar market.

1 Articles

STATSTAT
Center

Pharmalittle: We're reading about TrumpRx prices, a J&J psoriasis pill, and much more

Johnson & Johnson won approval for a daily psoriasis pill that rivals benefits of injectables and could roil a multibillion-dollar market.

·Boston, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States on Wednesday, March 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Johnson & Johnson icon

Johnson & Johnson

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal